All Stories

  1. Treating Thalassemia Patients with Luspatercept: An Expert Opinion Based on Current Evidence

    Article • Journal of Clinical Medicine, March 2023, MDPI AG

    Dr paolo ricchi

  2. Liver fibrosis in young patients with transfusion‐dependent thalassaemia (TDT), understanding the role of steatosis

    Article • British Journal of Haematology, October 2022, Wiley

    Dr paolo ricchi

  3. Special Issue: “Emerging Therapies and Strategies in Thalassemia: Toward a New Era in Management”

    Article • Journal of Clinical Medicine, September 2022, MDPI AG

    Dr paolo ricchi

  4. A case of ischemic colitis in a patient with non transfusion dependent thalassemia (NTDT) infected by SARS-COV-2

    Article • Pediatric Hematology and Oncology, May 2021, Taylor & Francis

    Dr paolo ricchi

  5. Thalassemia and hepatocellular carcinoma: links and risks

    Article • Journal of Blood Medicine, September 2019, Taylor & Francis

    Dr paolo ricchi

  6. MRI multicentre prospective survey in thalassaemia major patients treated with deferasirox versus deferiprone and desferrioxamine

    Article • British Journal of Haematology, October 2018, Wiley

    Dr paolo ricchi, VINCENZO POSITANO, Alessia Pepe

  7. The impact of liver steatosis on the ability of serum ferritin levels to be predictive of liver iron concentration in non-transfusion-dependent thalassaemia patients

    Article • British Journal of Haematology, January 2018, Wiley

    Dr paolo ricchi

  8. Soluble form of transferrin receptor-1 level is associated with the age at first diagnosis and the risk of therapeutic intervention and iron overloading in patients with non-transfusion-dependent thalassemia

    Article • Annals of Hematology, July 2017, Springer Science + Business Media

    Dr paolo ricchi

  9. Using fuzzy logic for improving clinical daily-care of β-thalassemia patients

    Article • July 2017, Institute of Electrical & Electronics Engineers (IEEE)

    Dr paolo ricchi

  10. Molecular and clinical analysis of haemoglobin Lepore in Campania, a region of Southern Italy

    Article • Hematology, February 2017, Taylor & Francis

    Dr paolo ricchi

  11. Myelolipoma among patients with thalassemia major and rare anemia with iron loading: A not so rare entity

    Article • American Journal of Hematology, February 2017, Wiley

    Dr paolo ricchi

  12. Extramedullary Haematopoiesis in Patients with Thalassaemia Major: Should We Search for It Regularly?

    Article • Acta Haematologica, January 2017, Karger Publishers

    Dr paolo ricchi

  13. The long-term and extensive efficacy of low dose thalidomide in a case of an untransfusable patient with Non-Transfusion-Dependent Thalassemia

    Article • Blood Cells Molecules and Diseases, March 2016, Elsevier

    Dr paolo ricchi

  14. Profile of deferasirox for the treatment of patients with non-transfusion-dependent thalassemia syndromes

    Article • Drug Design Development and Therapy, December 2015, Dove Medical Press

    Dr paolo ricchi

  15. Extramedullary hematopoiesis is associated with lower cardiac iron loading in chronically transfused thalassemia patients

    Article • American Journal of Hematology, October 2015, Wiley

    Dr paolo ricchi, Alessia Pepe

  16. Non-Transfusion-Dependent Thalassemia: A Complex Mix of Genetic Entities Yet to Be Fully Discovered

    Article • BioMed Research International, January 2015, Hindawi Publishing Corporation

    Dr paolo ricchi

  17. Renal cell carcinoma in adult patients with thalassaemia major: a description of three cases

    Article • British Journal of Haematology, February 2014, Wiley

    Dr paolo ricchi

  18. Unexpected prevalence of hyperprolactinaemia associated with microprolactinoma and empty sella in a cohort of adult patients with non-transfusion-dependent thalassaemia: a prospective study

    Article • British Journal of Haematology, November 2013, Wiley

    Dr paolo ricchi

  19. Nephrolithiasis in patients exposed to deferasirox and desferioxamine: probably an age-linked event with different effects on some renal parameters

    Article • Annals of Hematology, June 2013, Springer Science + Business Media

    Dr paolo ricchi

  20. Effect of splenectomy on iron balance in patients with β-thalassemia major: a long-term follow-up

    Article • European Journal Of Haematology, May 2013, Wiley

    Dr paolo ricchi

  21. Splenectomy is a risk factor for developing hyperuricemia and nephrolithiasis in patients with thalassemia intermedia: A retrospective study

    Article • Blood Cells Molecules and Diseases, October 2012, Elsevier

    Dr paolo ricchi

  22. A Useful Relationship Between the Presence of Extramedullary Erythropoeisis and the Level of the Soluble Form of the Transferrin Receptor in a Large Cohort of Adult Patients Affected by Thalassemia Intermedia:A Prospective Study

    Article • American Journal of Clinical Pathology, July 2012, Oxford University Press (OUP)

    Dr paolo ricchi

  23. A useful relationship between the presence of extramedullary erythropoeisis and the level of the soluble form of the transferrin receptor in a large cohort of adult patients with thalassemia intermedia: a prospective study

    Article • Annals of Hematology, December 2011, Springer Science + Business Media

    Dr paolo ricchi

  24. Hepatitis C virus distribution and clearance following interferon-monotherapy among thalassaemia major and intermedia patients

    Article • British Journal of Haematology, May 2011, Wiley

    Dr paolo ricchi

  25. A Case of Well-Tolerated and Safe Deferasirox Administration during the First Trimester of a Spontaneous Pregnancy in an Advanced Maternal Age Thalassemic Patient

    Article • Acta Haematologica, January 2011, Karger Publishers

    Dr paolo ricchi

  26. Prospective comparison on cardiac iron by MR in thalassemia major patients treated with combination deferipron-desferrioxamine versus deferipron and desferrioxamine in monoterapy

    Article • Journal of Cardiovascular Magnetic Resonance, January 2011, Springer Science + Business Media

    Dr paolo ricchi

  27. The impact of previous or concomitant IFN therapy on deferiprone-induced agranulocytosis and neutropenia: a retrospective study

    Article • Expert Opinion on Drug Safety, October 2010, Informa Healthcare

    Dr paolo ricchi

  28. Involvement of Akt/NF-κB pathway in N6-isopentenyladenosine-induced apoptosis in human breast cancer cells

    Article • Molecular Carcinogenesis, July 2010, Wiley

    Dr paolo ricchi

  29. Combined chelation therapy in thalassemia major with deferiprone and desferrioxamine: a retrospective study

    Article • European Journal Of Haematology, March 2010, Wiley

    Dr paolo ricchi

  30. Paradoxically Increased Ferritin Level in a Beta-Thalassemia Major Patient following the Start of Deferasirox Chelation Therapy

    Article • Acta Haematologica, January 2010, Karger Publishers

    Dr paolo ricchi

  31. Hypocholesterolaemia in Thalassaemia – Pathogenesis, Implications and Clinical Effects

    Article • European Oncology & Haematology, January 2010, Touch Digital Media, Ltd.

    Dr paolo ricchi

  32. Hypocholesterolemia in adult patients with thalassemia: a link with the severity of genotype in thalassemia intermedia patients

    Article • European Journal Of Haematology, March 2009, Wiley

    Dr paolo ricchi

  33. Hepatitis B virus reactivation during combined therapy with deferiprone and desferioxamine in a hepatitis B surface antigen thalassemic carrier

    Article • International Journal of Hematology, December 2008, Springer Science + Business Media

    Dr paolo ricchi

  34. Cyclo-Oxygenase Inhibition in Colorectal Adenomas and Cancer

    Article • Journal of Clinical Gastroenterology, October 2003, Wolters Kluwer Health

    Dr paolo ricchi

  35. Aspirin Protects Caco-2 Cells from Apoptosis after Serum Deprivation through the Activation of a Phosphatidylinositol 3-Kinase/AKT/p21Cip/WAF1Pathway

    Article • Molecular Pharmacology, July 2003, American Society for Pharmacology & Experimental Therapeutics (ASPET)

    Dr paolo ricchi

  36. Minireview: Nonsteroidal anti-inflammatory drugs in colorectal cancer: from prevention to therapy

    Article • British Journal of Cancer, March 2003, Nature

    Dr paolo ricchi

  37. Levovist-enhanced Doppler Sonography Versus Spiral Computed Tomography to Evaluate Response to Percutaneous Ethanol Injection in Hepatocellular Carcinoma

    Article • Journal of Clinical Gastroenterology, September 2000, Wolters Kluwer Health

    Dr paolo ricchi

  38. IGF-II/IGF-I receptor pathway up-regulates COX-2 mRNA expression and PGE2 synthesis in Caco-2 human colon carcinoma cells

    Article • Oncogene, January 2000, Nature

    Dr paolo ricchi

  39. A Phase I Study of Paclitaxel and Epirubicin, without and with Filgrastim, for the Treatment of Platinum-Resistant Advanced Ovarian Cancer

    Article • Oncology, May 1999, Karger Publishers

    Dr paolo ricchi

  40. Phase II Study of Cisplatin and Vinorelbine as First-Line Chemotherapy in Patients With Carcinoma of the Uterine Cervix

    Article • Journal of Clinical Oncology, March 1999, American Society of Clinical Oncology (ASCO)

    Dr paolo ricchi

  41. Effect of aspirin on cell proliferation and differentiation of colon adenocarcinoma Caco‐2 cells

    Article • International Journal of Cancer, December 1997, Wiley

    Dr paolo ricchi

  42. Effect of aspirin on cell proliferation and differentiation of colon adenocarcinoma Caco-2 cells

    Article • International Journal of Cancer, December 1997, Wiley

    Dr paolo ricchi

  43. Oestradiol and testosterone blood levels in patients with viral cirrhosis and hepatocellular carcinoma

    Article • European Journal of Gastroenterology & Hepatology, March 1997, Wolters Kluwer Health

    Dr paolo ricchi